62.44 F
New York
May 23, 2022

antiviral

Pfizer reports combined sales of $15 billion for Covid vaccine and antiviral treatment in first quarter

CNBC
CNBC – For more and to sign up click here Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange. Drew Angerer | Getty Images Pfizer beat on its top and bottom line in its first quarter earnings report,......

Merck sold $3.2 billion of its Covid oral antiviral treatment, driving first-quarter revenue growth

CNBC
CNBC – For more and to sign up click here Medicine pill is seen with Merck logo and words ‘Molnupiravir’ and ‘COVID-19’ displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. Jakub Porzycki | NurPhoto | Getty Images Merck sold $3.2......

U.S. to widen COVID antiviral pill distribution

Reuters
Pfizer’s coronavirus disease (COVID-19) pill Paxlovid is packaged in Ascoli, Italy, in this undated image obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS Register now for FREE unlimited access to Reuters.com Register WASHINGTON, April 26 (Reuters) – U.S. President Joe Biden’s administration is aiming to expand access to......

Pfizer to supply 4 million Covid antiviral treatments to poorer nations through UNICEF

CNBC
CNBC – For more and to sign up click here Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer | Handout | via Reuters Pfizer will supply up to 4 million courses of......

Canada approves Pfizer’s oral COVID-19 antiviral treatment, seeks supplies

Reuters
Travelers talk to a customs officer behind a “Mask Required” sign at Pearson International Airport during the coronavirus disease (COVID-19) pandemic of Toronto, Ontario, Canada, December 18, 2021. REUTERS/Carlo Allegri Register now for FREE unlimited access to Reuters.com Register OTTAWA, Jan 17 (Reuters) – Canada on Monday approved Pfizer Inc’s......

Biden speaks on fight against COVID and announces doubling of antiviral pill order

CBS News
CBS News – For more and to sign up click here Biden speaks on fight against COVID and announces doubling of antiviral pill order – CBS News Watch CBSN Live President Biden updated the nation on his administration’s efforts to contain COVID-19, announcing that he was doubling and accelerating the......

U.S. doubling and accelerating order of Pfizer antiviral pills

CBS News
CBS News – For more and to sign up click here President Biden announced on Tuesday that he’s directing his team to double the United States’ order of Pfizer antiviral pills from 10 million COVID-19 treatment courses to 20 million treatment courses, and the delivery will be accelerated from September......

Merck’s at-home antiviral COVID-19 pill gets U.S. authorization

Reuters
Dec 23 (Reuters) – The U.S. on Thursday authorized Merck & Co’s (MRK.N) antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc (PFE.N). The U.S. Food and Drug Administration said Merck’s drug which......

Biden says 250,000 treatment courses of Pfizer’s antiviral pill will be available in January

CNN
USA TODAY – For more and to sign up click here “With today’s action, we add the first-ever oral treatment to our nation’s medicine cabinet and take a significant step forward in our path out of the pandemic,” he added. “As soon as emerging science showed the promise of this......

FDA authorizes Pfizer’s Covid treatment pill, the first oral antiviral drug cleared during the pandemic

CNBC
CNBC – For more and to sign up click here The Food and Drug Administration granted emergency authorization Wednesday to Pfizer‘s Covid treatment pill, a major milestone that promises to revolutionize the fight against the virus. The medication, which is recommended for people at a high risk of developing severe......

Pfizer CEO: COVID antiviral pill reduces hospitalization rates up to 89% in high-risk adults

CBS News
CBS News – For more and to sign up click here Pfizer CEO: COVID antiviral pill reduces hospitalization rates up to 89% in high-risk adults – CBS News Watch CBSN Live Pfizer CEO Albert Bourla joins “CBS Mornings” on the one-year anniversary of the first Pfizer vaccine doses administered in......

Pfizer says new trial confirms high efficacy of its COVID antiviral pills

CBS News
CBS News – For more and to sign up click here Pfizer announced new results on Tuesday from studies testing its five-day course of COVID antiviral pills, confirming Paxlovid cut the risk of hospitalization or death in a trial for patients at high-risk of severe COVID-19 by 89% when treated......

Merck says its antiviral pill is less effective than initially reported.

New York Times
New York Times – For more and to sign up click here The pharmaceutical company Merck said on Friday that in a final analysis of a clinical trial, its antiviral pill reduced the risk of hospitalization and death among high-risk Covid patients by 30 percent, down from an earlier estimate......

U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million People

New York Times
New York Times – For more and to sign up click here WASHINGTON — The Biden administration plans to pay more than $5 billion for a stockpile of Pfizer’s new Covid-19 pill, enough for about 10 million courses of treatment to be delivered in the next 10 months, according to......

The U.S. plans to buy enough of Pfizer’s Covid antiviral pills for 10 million people.

New York Times
The Biden administration is planning to pay more than five billion dollars for a stockpile of Pfizer’s new Covid-19 pill, enough for about 10 million courses of treatment, after the company gears up production next year, according to people familiar with the agreement. Senior federal health officials describe the pill......

UK to roll out COVID-19 antiviral drug trial this month -Health Security Agency

Reuters
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021. Merck & Co Inc/Handout via REUTERS LONDON, Nov 7 (Reuters)......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More